| CD44(+) fibroblasts increases breast cancer cell survival and drug resistance via IGF2BP3-CD44-IGF2 signalling | |
| Liu, Yonglei; Yu, Conghui; Wu, Yonggang; Sun, Xiangjun; Su, Quanping; You, Cuiping; Xin, Hongwu | |
| 刊名 | JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
 |
| 2017 | |
| 卷号 | 21期号:9 |
| 关键词 | breast cancer IGF2BP3 IGF2 fibroblasts |
| ISSN号 | 1582-4934 |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/3612554 |
| 专题 | 复旦大学上海医学院 |
| 推荐引用方式 GB/T 7714 | Liu, Yonglei,Yu, Conghui,Wu, Yonggang,et al. CD44(+) fibroblasts increases breast cancer cell survival and drug resistance via IGF2BP3-CD44-IGF2 signalling[J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE,2017,21(9). |
| APA | Liu, Yonglei.,Yu, Conghui.,Wu, Yonggang.,Sun, Xiangjun.,Su, Quanping.,...&Xin, Hongwu.(2017).CD44(+) fibroblasts increases breast cancer cell survival and drug resistance via IGF2BP3-CD44-IGF2 signalling.JOURNAL OF CELLULAR AND MOLECULAR MEDICINE,21(9). |
| MLA | Liu, Yonglei,et al."CD44(+) fibroblasts increases breast cancer cell survival and drug resistance via IGF2BP3-CD44-IGF2 signalling".JOURNAL OF CELLULAR AND MOLECULAR MEDICINE 21.9(2017). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论